1.876 - 1.900 of 34.217
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Aixtron Call 14,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,80x
- Analysis
- Meta Platforms Call 860,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 8,92x
- Analysis
- RWE St. Call 35,00 18 Jun 2027
- Goldman Sachs
- 18.06.27
- 4,06x
- Analysis
- DELL UN Call 220,00 18 Jun 2026
- Goldman Sachs
- 18.06.26
- 5,11x
- Analysis
- Super Micro Computer Call 40,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 5,09x
- Analysis
- Deutsche Telekom Call 25,00 18 Jun 2027
- Goldman Sachs
- 18.06.27
- -
- Analysis
- Moderna Call 24,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 3,64x
- Analysis
- R3NK GY Call 60,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 8,43x
- Analysis
- Novo Nordisk Call 285,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,55x
- Analysis
- Alphabet Call 340,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,65x
- Analysis
- Commerzbank Call 60,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 5,39x
- Analysis
- Gilead Sciences Call 200,00 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 5,22x
- Analysis
- Meta Platforms Call 1.020,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 15,65x
- Analysis
- Moderna Call 24,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 4,39x
- Analysis
- Novo Nordisk Call 475,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,45x
- Analysis
- Novo Nordisk Call 355,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,88x
- Analysis
- Novo Nordisk Call 255,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,35x
- Analysis
- Henkel Vz. Call 72,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 15,37x
- Analysis
- Meta Platforms Call 810,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 21,74x
- Analysis
- Novo Nordisk Call 525,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,29x
- Analysis
- Novo Nordisk Call 415,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,19x
- Analysis
- Novo Nordisk Call 295,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,64x
- Analysis
- Novo Nordisk Call 305,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,73x
- Analysis
- Novo Nordisk Call 275,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,51x
- Analysis
- Novo Nordisk Call 385,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,90x
- Analysis